Stanmore Tumour OutcoMes Project (STOMP)

  • Research type

    Research Study

  • Full title

    Stanmore Tumour OutcoMes Project (STOMP): Measuring survivorship and rehabilitation outcomes after treatments for bone and soft tissue tumours

  • IRAS ID

    291087

  • Contact name

    Sherron Furtado

  • Contact email

    sherron.furtado@nhs.net

  • Sponsor organisation

    Royal National Orthopaedic Hospital NHS Trust

  • Duration of Study in the UK

    10 years, 0 months, 1 days

  • Research summary

    Background:
    Treatment for musculoskeletal (bone or soft tissue) tumours is routinely life changing. Typical treatment involves surgery to remove large amounts of muscle and/or bone or amputation, radiotherapy and chemotherapy. After treatment patients may be less active, bed bound or struggle with everyday tasks, which significantly affects physical, psychological and social health, quality of life and life expectancy. There is a need for scientifically tested,
    comprehensive measurement approaches to shed light on the complex needs of
    patients and identify areas requiring attention. The previously tested World
    Health Organisation recommended, “International Classification of Functioning,
    Disability and Health (ICF)” which captures a range of outcomes important to patients could be the solution in patients treated for musculoskeletal tumours.

    Aim of the research
    The main aim of this project is to capture how patient's fare after surgery and for this tumour are likely to include mobility problems, quality of life issues and barriers to return to normal life experiences during and after treatment for musculoskeletal tumours.

    Design and methods used
    In the proposed study we will enrol patients including children
    (6-18 years old) and adults (>18 years old) treated for musculoskeletal tumours at the Royal National Orthopaedic Hospital NHS Trust. To do this we will perform ICF assessments which can comprehensively capture patient's experiences and usually comprise of outcome assessment tools embedded within this framework (depending on individual patient's age, diagnosis, treatment). Likely sections (and not limited to) under which outcomes will be collected are: 1) physical disabilities and QoL using standard questionnaires 2) real-world (at home) mobility using wearable digital technology in all patients and detailed gait assessments in hospital. Patients will be asked about their perceptions of recovery, physical disabilities and QoL and factors facilitating or posing a barrier to recovery after surgery. Tumour, patient and treatment factors which predict those at risk of poor outcomes will be explored.

  • REC name

    Wales REC 1

  • REC reference

    21/WA/0027

  • Date of REC Opinion

    3 Nov 2021

  • REC opinion

    Further Information Favourable Opinion